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Abstract
Background: Understanding factors associated with variation in hospital charges may help identify
means to increase savings. The aim of the present study was to define potential variation in hospital
charges associated with hepatopancreatobiliary(HPB) surgery.
Methods: Patients who underwent an HPB procedure between 2009–2013 were identified. Total
hospital charges were tabulated for room and board, surgical/anaesthesia services, medications,
laboratory/radiology services and other miscellaneous charges.
Results: Approximately 2545 patients underwent either a pancreas (66.8%) or liver/biliary (33.2%)
resection. The mean total charges for all patients were $42 357  33 745 (pancreas: $46 352 
34 932 versus the liver: $34 303  29 639; P < 0.001). Morbidity (pancreas, range: 7–18%; liver,
range: 9–18%) and observed:expected (O:E) length of stay (LOS)(pancreas, range: 0.67–1.64; liver,
range: 1.06–3.35) varied among providers (both P < 0.001). While a peri-operative complication
resulted in increased total hospital charges (complication: $66 401  55 124 versus no complication:
$39 668  29 250; P < 0.001), total charges remained variable even among patients who did not
experience a complication (P < 0.001). Surgeons within the lowest quartile of O:E LOS had lower total
charges ($33 879  $27 398) versus surgeons in the highest quartile ($49 498  40 971) (P < 0.001).
Surgeons with the highest O:E LOS had higher across-the-board charges (operating room, highest
quartile: $10 514  $4496 versus lowest quartile: $7842  $3706; medication, highest quartile: $1796
 $3799 versus lowest quartile: $925  $2211; radiology, highest quartile: $2494  $4683 versus low-
est quartile: $1424  $3247; P = 0.001; laboratory, highest quartile: $4236  $5991 versus lowest
quartile: $3028  $3804; all P < 0.001).
Conclusions: After accounting for in-hospital complications, the total mean hospital charges for HPB
surgery remained variable by case type and provider. While the variation in charges was associated
with LOS, provider-level differences in across-the-board charges were also noted.
Received 12 March 2015; accepted 6 May 2015
Correspondence
Timothy M. Pawlik, MD, MPH, PhD, FACS, Professor of Surgery and Oncology, Chief, Division of
Surgical Oncology, John L. Cameron Professor of Alimentary Surgery, Department of Surgery, Johns
Hopkins Hospital, 600 N. Wolfe Street, Blalock 688, Baltimore, MD 21287, USA. Tel.:+1 410 502 2387.
Fax: +1 410 502 2388. E-mail: tpawlik1@jhmi.edu
Introduction
Clinical parameters, such as peri-operative length-of-stay
(LOS), morbidity and mortality, are commonly associated with
quality of care.1 In turn, most reported data on surgical quality
have largely focused on these factors in an attempt to improve
overall surgical outcomes. More recently, the concept of ’value‘
has emerged as an important health care metric that has
garnered the interest of both payors and providers.2 Value is a
concept that encompasses quality, yet also takes into account
health care costs. As Porter has pointed out, value is defined as
outcomes relative to costs and, therefore, encompasses effi-
ciency and should be the overarching goal of health care deliv-
ery.2 The cost of care for specific surgical procedures has not,
however, been well studied.3,4 The increasing cost of healthcare
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in the United States (US) is of critical importance and, there-
fore, a more focused evaluation of both traditional quality
metrics (i.e. LOS, morbidity, mortality, etc.), but also the
financial impact of surgical interventions is needed.
One particular area of interest in health care cost control has
been efforts to understand, as well as minimize or eliminate,
unwanted variation. Previous studies have established that con-
siderable variation exists in the US healthcare system with
regards to quality of care.5–7 The impact of the cost of care, as
well as variation in cost, on clinical outcomes, however, have
been mixed.8,9 Several studies have reported on the cost of care
after various operations in gynaecology,10 orthopaedic,11,12
vascular,13 ear nose and throat14,15 and general surgery.3,16–18 In
one study, Fox et al. reported a significant variation in hospital
costs after a colectomy for cancer and noted that cost variation
did not correlate with surgical outcomes.18 In a separate study,
Nathan et al. reported on elderly patients receiving surgical care
for six common surgical operations and similarly noted substan-
tial variation in the cost of care.19 Such studies highlight how
variations in the cost of care exist at the national and institu-
tional level. These studies, however, have largely not examined
variation in cost at the provider level.
Examining variations in cost of care is particularly important
for patients undergoing hepatopancreatobiliary (HPB) surgery.
The number of HPB cases has increased substantially over the
last several decades with over 45 000 procedures performed
annually in the US.20 HPB operations typically require more
peri- and intra-operative resources than general surgery cases,
potentially increasing costs associated with HPB operations.21
HPB operations may also be associated with a higher incidence
of morbidity, as well as a longer LOS than general surgery
cases.21,22 As such, examining the financial impact of HPB pro-
cedures, as well as the variation in costs/charges, is important.
Specifically, understanding factors associated with variation in
procedure-related charges may help identify means to increase
savings. To date, charge/cost variation among patients under-
going HPB operations has not been well studied. Furthermore,
no study has explicitly analysed the variations in charges/cost
among HPB surgeons in a single, fixed institutional setting.
Therefore, the aim of the present study was to define potential
variation in hospital charges among a group of HPB surgeons
at a high-volume tertiary academic medical centre. In particu-
lar, we sought to characterize the variation in HPB hospital
charges among providers relative to quality metrics such as in-
hospital complications and LOS.
Patients and methods
All patients undergoing pancreas (pancreaticoduodenectomy,
total pancreatectomy, partial pancreatectomy, proximal
pancreatectomy and distal pancreatectomy) and liver (partial
hepatectomy and hepatic lobectomy) resections for malignancy
between 2009 and 2013 at Johns Hopkins Hospital were identi-
fied using the appropriate International Classification of
Diseases (ICD-9) procedure codes (52.7, Whipple procedure;
52.6, total pancreatectomy; 52.59, partial pancreatectomy;
52.51, proximal pancreatectomy; 52.52, distal pancreatectomy;
52.96, pancreatic anastomosis; 50.3, hepatic lobectomy; and
50.22, partial hepatectomy). Standard data on demographic,
clinicopathological and treatment-related variables were col-
lected. Specifically, data including age, sex, race, American
Society of Anesthesiologist (ASA) class and Charlson’s co-mor-
bidity index scores were collected. Patients were stratified based
on observed:expected (O:E) LOS. Expected LOS is defined as
the calculated geometric mean estimated LOS based on each
individual Medicare severity diagnosis-related group for the
fiscal year 2013.23
The presence of an in-hospital peri-operative complication
was ascertained through discharge ICD-9 diagnosis codes as
previously described24 and included minor infections (urinary
tract infection, surgical site infection and Clostridium difficile
infection), major infections (sepsis, ventilator-associated pneu-
monia and drug-resistant infections), transient ischaemic
attack, cerebrovascular attack, myocardial infarction, venous
thromboembolism events (deep vein thrombosis and pul-
monary embolism) and disseminated intravascular coagulation.
Peri-operative mortality was defined as death in the hospital or
within 90 days from the date of surgery.25
Economic analysis
An economic analysis was performed based on all charges
assessed during the index hospitalization. Total charges were
tabulated based on all hospital services provided including
room and board, surgical and anaesthesia services, medications,
laboratory and radiology services, physical/occupational/speech
therapy and other miscellaneous charges as previously
described.26 Charges were administered and calculated based
on a fixed internal hospital fee allowing for direct comparison
among patients.27 Fixed charges were defined as those related
to routine room and board charges whereas variable charges
included the remaining surgical and anaesthesia services, medi-
cations, laboratory and radiology services, physical/occupa-
tional/speech therapy and other miscellaneous charges. All
values were inflation-adjusted and expressed in 2012 US dol-
lars.
Statistical analysis
Discrete variables are described as medians with interquartile
range whereas continuous data are described as means with
standard deviation. Categorical variables are noted as totals
and frequencies. Univariate comparisons were assessed using
the chi-squared, analysis of variance test or Mann–Whitney
U-test as appropriate. Normality was assessed using the Shapiro–
Wilk test. All analyses were carried out using STATA version
13.0 (StataCorp, College Station, TX, USA), and a P-value of
< 0.05 (two-tailed) was considered statistically significant.
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Results
Approximately 2545 patients who underwent either a liver
(n = 844, 33.2%) or pancreas (n = 1701, 66.8%) resection were
identified (Table 1). Females (n = 1294, 50.8%) slightly out-
numbered males (n = 1251, 49.2%), whereas the majority of
the patients were of a white race (n = 2071, 81.4%). Comor-
bidities were common as the median ASA class and Charlson’s
score were 3 [interquartile range (IQR: 2, 3) and 5 (IQR: 2,
6)], respectively. For the entire cohort, the median LOS was
7 days (IQR: 5, 11), whereas the expected average LOS
was 8 days (IQR: 6.3, 10). The median and expected LOS was
higher for patients after a pancreas (observed LOS: 8 days,
IQR: 6, 13 days; expected LOS: 9 days, IQR: 6.75, 10.5 days)
versus a liver (observed LOS: 5 days, IQR: 4, 7 days; expected
LOS: 6.5 days, IQR: 6, 8 days) resection. A peri-operative com-
plication occurred in 14.4% of patients and was higher among
those undergoing a pancreas (n = 286, 16.8%) versus a liver
(n = 80, 9.5%) resection. The occurrence of a peri-operative
complication resulted in an average of 7 extra hospital days
(median LOS: 14 days, IQR: 8, 21; P <0.001) (Table 2).
After stratifying patients by O:E LOS, a majority of patients
had an O:E LOS ≤ 1 (n = 1471, 57.8%). Patients with an O:E
LOS > 1 did not differ with regards to age, comorbidities (e.g.
average ASA and Charlson’s scores), or race as compared with
an O:E LOS ≤ 1 (all P > 0.05). Patients undergoing a pancreas
resection, however, had on average a higher O:E LOS versus
patients undergoing a liver resection (pancreas: 1.28  0.94
versus liver: 0.92  0.80; P < 0.001).
Hospital charge analysis stratified by resection type
The mean total hospital charges for all patients were
$42 357  33 745. Patients undergoing a pancreas resection
had higher mean charges compared with patients undergoing a
liver resection (pancreas: $46 352  34 932 versus liver:
$34 303  29 639, D 23.8%; P < 0.001). On average, fixed
charges for room and board accounted for nearly half of all
hospital charges (45.7%) with the remaining charges attributa-
ble to operating room (25.9%), supply (11.0%), laboratory
(8.5%), radiology (3.3%), medication (2.8%), therapy (1.0%)
and miscellaneous (1.8%) charges. LOS accounted for the
majority of charge variation as, on average, each additional
hospital day resulted in an increase in $3975 (95% CI $3901–
$4049; R2 = 0.81).
Given that the presence of a peri-operative complication
resulted in an average of 7 extra hospital days, the presence of
a peri-operative complication resulted in nearly double the
hospital charges (no peri-operative complication: $37 442 
25 758 versus a peri-operative complication: $71 515 
54 543, D 47.6%; P < 0.001). After adjusting for the extra
Table 1 Clinicopathological characteristics of cohort stratified by observed:expected (O:E) length of stay (LOS)
All (n = 2545) O:E LOS ≤ 1 (n = 1471) O:E LOS > 1 n = (1074) P-value
Age, years, median (IQR) 62 (52, 71) 62 (50, 70) 62 (52, 71) 0.48
Male Gender 1251 (49.2) 707 (48.1) 544 (50.7) 0.101
White Race 2071 (81.4) 1207 (82.2) 864 (80.5) 0.77
ASA Class 3 & 4 1705 (74.0) 1008 (74.8) 697 (73.0) 0.33
Charlson score >3 1256 (54.5) 800 (59.4) 456 (47.7) <0.001
Most common diagnoses
Pancreatic head tumour 569 (22.4) 362 (24.6) 207 (19.3) <0.001
Procedure type
Pancreaticoduodenectomy 1122 (44.1) 511 (34.7) 611 (56.9) <0.001
Distal pancreatectomy 390 (15.3) 269 (18.3) 121 (11.3)
Partial hepatectomy 615 (24.2) 467 (32.8) 148 (13.8)
Hepatic lobectomy 78 (3.1) 44 (3.0) 34 (3.2)
IQR, interquartile range.
Table 2 Hospital length of stay and associated hospital charges owing to peri-operative morbidity
Outcome N (%) Length of stay Total costs Fixed costs Variable costs
No complication 2179 (85.6) 7 (5, 9) 37 442  25 758 17 609  14 081 19 832  13 289
Any complication 366 (14.4) 14 (8, 21) 71 515  54 543 35 283  27 249 36 333  30 764
P-value – <0.001 <0.001 <0.001 <0.001
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increase in LOS, the presence of a peri-operative complication
independently resulted in an increase of $2869 (95% CI
$1134–$4604) in hospital charges. Patients undergoing a liver
resection ($7234, 95% CI $4059–$10 410) had an independent
higher mean increase in charges owing to a peri-operative
complication compared with patients who experienced a
morbidity after a pancreas resection ($1435, 95% CI $ $-574,
$3444) (P < 0.001).
Hospital charge analysis stratified by surgeon
A total of 14 surgeons accounted for the 2545 operations
included in the cohort. Overall average hospital charges per
surgeon ranged from $29 375  21 731 to $78 092  56 262
(D 62.4%; P < 0.001). The average O:E LOS for all surgeons
was 1.16  0.9 (range: 0.79-2.05). Surgeons within the lowest
quartile of O:E LOS had lower total charges ($34 371 
$30 357) versus surgeons in the highest O:E LOS quartile
($51 864  40 202) (D 33.7%, P < 0.001). These lower charges
among surgeons within the lowest quartile of O:E LOS were
probably due in part to the lower incidence of peri-operative
morbidity among these surgeons (lowest quartile: 10.5% versus
highest quartile: 19.1%) resulting in a shorter average LOS
(lowest quartile: 5 days, IQR: 4, 7 versus highest quartile:
9 days, IQR: 7, 14; P < 0.001) (Fig. 1). Surgeons with the
highest O:E LOS had higher across-the-board charges versus
surgeons with the lowest O:E LOS (operating room, highest
quartile: $10 514  $4496 versus lowest quartile: $7842 
$3706; medication, highest quartile: $1796  $3799 versus low-
est quartile: $925  $2211; radiology, highest quartile: $2494
 $4683 versus lowest quartile: $1424  $3247; P = 0.001; lab-
oratory, highest quartile: $4236  $5991 versus lowest quartile:
$3028  $3804; all P < 0.001) (Fig. 2).
To mitigate differences in charges owing to the two largest
confounders found in the data (LOS and perioperative mor-
bidity), a sub-analysis was performed to assess the potential
variation in charges among surgeons controlling for these
factors. For the purpose of this analysis, the two most common
operations (pancreaticoduodenectomy and partial hepatec-
tomy) were evaluated; in addition, only patients who (i) were
operated on by a surgeon with at least 10 cases, (ii) did not
experience a peri-operative morbidity and (iii) had an LOS
representing the 25th, 50th, and 75th percentile for that partic-
ular operation were included. Among patients who had no
documented peri-operative morbidity and an LOS of 6, 8 or
13 days after a pancreaticoduodenectomy, considerable charge
variation persisted among surgeons (Table 3). In fact, there
was significant variation in across-the-board charges among all
surgeons (Fig. 3) (all P < 0.001). Similarly, among patients
who had no documented peri-operative morbidity and an LOS
of 4, 5 or 7 days after a partial hepatectomy, there was sub-
stantial charge variation among surgeons (Table 4), with signif-
icant surgeon variation noted in all charges across the board
(Fig. 4) (all P < 0.001).
Discussion
Unwanted variation describes the concept of variation in health-
care not explained by illness, patient preference or the dictates
of evidence-based medicine.28 Variation in the cost of care
undoubtedly falls within this domain, especially as previous
studies have described how increased costs in care do not
necessarily result in improved clinical outcomes.8,9 As such,
determining variation in the costs of care and associating these
Figure 1 Variation in length of stay (LOS) and morbidity rates
stratified by observed:expected (O:E) LOS
Figure 2 Variation in hospital charges for the entire cohort
stratified by observed:expected (O:E) length of stay (LOS)
(P < 0.001). OR, operating room
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costs with clinical outcomes is necessary to target unnecessary
waste in healthcare delivery. While several previous studies have
examined variation in cost among specific patient populations,
data on HPB surgery are limited. This study is, therefore,
important as we defined the variation in hospital charges among
a group of HPB surgeons at a high-volume tertiary academic
medical centre using raw hospital charges. Specifically, we noted
that, in addition to differences in per-ioperative morbidity and
LOS, significant variation existed among providers with regards
to overall hospital charges after HPB surgery. Although
additional hospital days were the main drivers behind this dif-
ference, the incidence of a peri-operative complication indepen-
dently increased hospital charges by nearly $3000. Perhaps
equally as important, there was significant variation among sur-
geons for across-the-board charges, as well as for certain quality
metrics. Specifically, based on Medicare severity diagnosis-
related group calculations for expected LOS, surgeon O:E LOS
ranged from 0.79 to 2.05 and the overall mean hospital charges
differed by a maximum of 62.4% among providers.
LOS after surgery has routinely been assessed and targeted
as a metric to improve healthcare quality and costs. The
impact of extended or prolonged LOS on hospital costs has
been well described in a variety of other surgical sub-special-
ties.29,30 Consequently, there have been directed efforts to min-
imize LOS through various standardized ’fast-track‘ or
’enhanced recovery‘ protocols after a variety of operations.31–33
In general, these protocols have yielded promising results. For
example, Roulin et al. reported that an enhanced recovery
protocol resulted in an average decreased LOS of 3 days after
colorectal surgery, resulting in an average saving of €1651 per
patient.32 In the present study, we noted that extended LOS
was the main driving force between variations in charges after




















LOS of 13 days
A 20.0 9 (7, 15) 1.39  1.00 9 (7, 13) 14 905  2964 17 398  3816 22 834  5074
B 23.7 8 (7, 10) 1.20  0.66 7 (7, 10) 17 750  4115 19 408  4417 –
C 23.8 12 (9, 19) 1.50  0.65 10 (8, 13) 16 351 22 082  4040 25 545  1590
D 10.2 9 (6, 14) 1.27  0.77 8 (6, 11) 15 132  2506 21 721  3163 –
E 13.8 8 (7, 10) 1.12  0.69 8 (7, 10) 16 611  4015 19 670  4669 –
F 20.6 8 (6, 14) 1.46  1.20 7 (6, 12) 20 435  4803 22 821  2732 25 023  6606
G 12.9 7 (6, 10) 1.03  0.59 7 (6, 9) 19 784  2804 21 758  3313 28 639
H 15.0 9 (7, 15) 1.29  0.70 8 (7, 13) 15 924  2258 17 508  2974 20 613  5221
I 20.0 8 (7, 14) 1.16  0.73 8 (7, 11) 21 679  3293 23 818  5623 30 170
J 25.6 10 (7, 15) 1.43  1.04 8 (6, 13) 16 206  3983 18 857  3129 24 700  3709
P-value 0.27 0.009 0.01 0.42 <0.001 <0.001 <0.001
O:E, observed:expected; LOS, length of stay; IQR, interquartile range; SD, standard deviation.





















LOS of 7 days
A 13.6 9 (7, 15) 0.97  0.71 9 (7, 10) 26 792  26 145 16 152 20 513  9888
B 13.3 6 (5, 8) 1.53  0.61 6 (5, 8) 12 892  7.226 12 340  628 17 577  5758
C 6.9 4 (3, 5) 0.64  0.29 4 (3, 5) 15 496  3763 18 115  4580 16 429  1382
D 20.0 6 (5, 7) 1.0  0.67 5.5 (5, 6) 11 704  5607 17 953  2539 19 174  6340
E 11.1 4 (3, 5) 0.77  0.58 4 (3, 5) 15 847  5031 18 632  5130 21 852  1011
F 16.1 7 (5, 8) 1.40  1.78 6 (5, 7) 11 487  4418 15 310  2742 20 376  5054
G 6.3 7.5 (6, 9) 0.97  0.37 7 (6, 9) 14 397 21 735 23 033  10 558
H 30.4 7 (4, 9) 1.11  1.36 6 (4, 7) 10 483  3316 – 11 499  2253
P-value 0.02 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
O:E, observed:expected; LOS, length of stay; IQR, interquartile range; SD, standard deviation.
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HPB surgery. In fact, each additional hospital day was respon-
sible for nearly $4000 in extra hospital charges. Although these
costs were largely fixed on room and board charges, an
increased LOS also resulted in increased across-the-board
charges from variable charges such as those stemming from the
laboratory, supply and radiology use. These data provide evi-
Figure 3 Variable charges after a pancreaticoduodenectomy for patients with a length of stay (LOS) of 8 days and no complications (all
P < 0.001). OR, operating room
Figure 4 Variable charges after a hepatectomy for patients with a length of stay (LOS) of 4 days and no complications (all P < 0.001).
OR, operating room
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dence that reducing overall LOS can help reduce hospital
charges and should be an area for focused improvement.
Increased efforts should be made to target and reduce the
extended LOS among patients undergoing HPB surgery when
clinically appropriate. To this end, several centres have intro-
duced enhanced recovery protocols aimed specifically at
patients undergoing HPB surgery.34,35 Page et al. have noted
that enhanced recovery HPB protocols should focus on mini-
mizing (i) the stress of laparotomy, (ii) the use of opioids, (iii)
blood loss and blood product transfusions and (iv) peri-opera-
tive fasting.31 While other centres have already implemented
HPB-specific enhanced recovery pathways in the post-operative
setting, these protocols are only currently being introduced at
our own institution.
Similar to most other surgical procedures, there is demon-
strable variation in the quality of care and clinical outcomes
after HPB operations. For example, Birkmeyer et al. described
a now well-established association between hospital volume
and in-hospital mortality among patients undergoing a pancre-
aticoduodenectomy.36 Other authors, including our own
group, have further examined the volume-outcome relation-
ship and have noted that significant variation exists among
both hospitals and surgeons after HPB surgery.22,37 Interest-
ingly, even in the present study when considering experienced
surgeons at a very high-volume centre, we noted variation in
morbidity, as well as LOS among providers. For example, even
after adjusting for Medicare severity diagnosis-related groups,
surgeon O:E LOS ranged from 0.79 to 2.05 and morbidity ran-
ged from 5.6 to 20.3%. In addition, perhaps not surprisingly,
we noted a strong association of morbidity with LOS – as
patients who experienced a peri-operative complication spent
an average of 7 days longer in the hospital. Although the
increased hospital stay was largely responsible for the nearly
50% increase in hospital charges, the incidence of a peri-opera-
tive complication independently resulted in nearly $3000 extra
in hospital charges per patient. Of note, these data are compa-
rable to Nathan et al. who reported that surgical complications
resulted in an increase of between 47% and 70% in hospital
costs among elderly patients undergoing a cancer resection.19
As calls for open-access to surgical performance become lou-
der, these data will have potential serious implications. Specifi-
cally, not only will metrics such as LOS and morbidity be
increasingly scrutinized, but so will individual surgeon- and
hospital-specific data on costs of care. As such, it is important
to identify and define the variation in charges/cost among pro-
viders so that targeted interventions can be developed to
reduce these excessive hospital costs.
It is important to note that the differences in charges at the
surgeon level persisted despite adjustment for differences in
LOS and peri-operative morbidity. Several studies have shown
that despite standardized protocols for certain aspects of peri-
operative care, such as the use of blood products, laboratory
tests, or radiographic exams, significant variation in the use of
these resources still exists among surgeons.24 In the present
study, we noted large variations in across-the-board charges
among surgeons despite comparable outcomes after HPB
surgery. For example, among patients undergoing a pancreati-
coduodenectomy, operating room charges varied from the
highest to lowest charging surgeon by 36.7% (Fig. 4). Similarly,
the use of radiographs differed significantly among patients
with no peri-operative complication with the charges varying
by a surprising 81.8% between the highest and lowest charging
surgeon. A similar high variation in across-the-board charges
was noted after a liver resection among patients who had com-
parable good outcomes (i.e. same LOS, no complications).
Collectively, these data strongly suggest that variations in cost
are considerable and that some providers may inherently be
inclined to utilize more resources than others. In addition,
based on our stratified subset analyses of only patients who
did not experience a peri-operative morbidity and had a LOS
representing the 25th, 50th and 75th percentile, the data sug-
gest that higher charges do not necessarily equate with a better
clinical outcome. With the increasing cost of healthcare, such
data emphasize how variation in cost is, in part, provider dri-
ven. In turn, these data highlight the need to develop individ-
ual provider-based tools or dashboards to assist clinicians in
understanding and controlling their costs.
There are several limitations that need to be considered when
interpreting the data. Given that complication data were
obtained from chart abstraction using ICD-9 codes, the overall
complication rate may be under-reported. As peri-operative
morbidity was a strong predictor of charge variation, this limita-
tion is likely random and would serve only to underestimate the
true variation in hospital charges noted in the data. Second, our
analyses utilized hospital charges as opposed to estimating the
actual cost of treatment. However, as all hospital charges came
from a single institution based on fixed internal fees for each
service provided, comparisons of the differences and variation of
the economic impact among surgeons within our institution are
not be affected by the use of charge rather than cost data. Finally,
our data is limited in the fact that only charge data for the index
hospitalization were available. Previous studies have shown,
however, that readmission and its impact on hospital costs is rel-
atively low among patients undergoing a cancer resection when
compared with the index hospitalization.19
In summary, significant variation exists in hospital charges
among surgeons after HPB operations. Although LOS and the
incidence of peri-operative complications account for the
majority of these differences, surgeon variation in charges/costs
exists independent of these factors. As such, a critical analysis
of surgeon-specific hospital charges after surgery should be
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